Outcomes for the anatomic hybrid glenoid total shoulder arthroplasty system, A 6-year median follow-up
Chandar Jaipal, Alistair Eyre-Brook, James Vun, Marius Espag, Tim Cresswell, David Clark, Amol TambeBackground
The next-generation anatomic total shoulder arthroplasty with hybrid glenoid fixation (AHG) is designed to reduce the incidence of glenoid component loosening. The primary aim is to assess the survival of AHG implant.
Methods
Retrospective review of prospectively collected data on AHG between 2010 and 2020, including Clinical data, radiographs, Oxford Shoulder (OSS) and Constant Shoulder scores, which were collected and analysed using GraphPad Prism.
Results
A total of 51 AHGs in 46 patients were identified with median 6.0 years follow-up (IQR 4.8–7.0 years). Only one case required revision for aseptic loosening of the glenoid component at 3 years. Overall survivorship of AHG was 97.6% at 7 years. OSS at 1 year improved significantly (median: 42, IQR 35–48 vs. median: 20, IQR 15–26.5;
Discussion
AHG implants demonstrate a high survivorship rate whilst maintaining excellent range of movement and patient-reported outcome scores to support its continued use.